<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Andrew D. Eustace | Oswestry Keele Orthopaedic Research group - OsKOR</title>
    <link>https://oskor.netlify.app/author/andrew-d.-eustace/</link>
      <atom:link href="https://oskor.netlify.app/author/andrew-d.-eustace/index.xml" rel="self" type="application/rss+xml" />
    <description>Andrew D. Eustace</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-gb</language><copyright>Â© 2025</copyright><lastBuildDate>Fri, 12 Jul 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png</url>
      <title>Andrew D. Eustace</title>
      <link>https://oskor.netlify.app/author/andrew-d.-eustace/</link>
    </image>
    
    <item>
      <title>Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis</title>
      <link>https://oskor.netlify.app/publication/soluble-syndecan-3-binds-chemokines-reduces-leukocyte-migration-in-vitro-and-ameliorates-disease-severity-in-models-of-rheumatoid-arthritis/</link>
      <pubDate>Fri, 12 Jul 2019 00:00:00 +0000</pubDate>
      <guid>https://oskor.netlify.app/publication/soluble-syndecan-3-binds-chemokines-reduces-leukocyte-migration-in-vitro-and-ameliorates-disease-severity-in-models-of-rheumatoid-arthritis/</guid>
      <description>
&lt;script src=&#34;https://oskor.netlify.app/publication/soluble-syndecan-3-binds-chemokines-reduces-leukocyte-migration-in-vitro-and-ameliorates-disease-severity-in-models-of-rheumatoid-arthritis/index.en_files/header-attrs/header-attrs.js&#34;&gt;&lt;/script&gt;


</description>
    </item>
    
  </channel>
</rss>
